San Francisco, California Cancer Immunology Discovery Unit

Site Statistics: State-of-the-art facility with specialized laboratories and equipment

Functions: Discovery, Protein Engineering and Biology

Primary Therapeutic Areas: Oncology, Cancer immunology

Key Technologies: Next generation bio-therapeutics

The Cancer Immunology Discovery (CID) team in South San Francisco is focused on the generation of large molecule immunotherapeutics that promote anti-tumor activity or counter immunosuppression in the tumor microenvironment. To achieve this goal, protein engineers, immunologists and cancer biologists at CID combine talents to advance projects from concept to clinical compounds. Protein engineering efforts are supported by a world class antibody generation program, and a commitment to effective biotherapeutic design that stresses both ingenuity and simplicity. Our immunologists and cancer biologists take a holistic approach to understanding the interplay of tumor, stromal and immune cells in the tumor microenvironment, striving to define the axes of intercellular communication that could be leveraged to generate novel therapeutics.